Becker's Healthcare July 8, 2024
Eli Lilly will acquire Morphic, a Massachusetts-based biopharmaceutical company, for about $3.2 billion by the end of 2024.
Morphic’s lead product is an oral small molecule inhibitor that is a potential inflammatory bowel disease treatment, according to a July 8...